4.1 Editorial Material

Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL)

Related references

Note: Only part of the references are listed.
Review Oncology

Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis

Carlo Visco et al.

Summary: Through a systematic review, it was found that combination therapy with NPLD (R-COMP) is comparable to standard treatment (R-CHOP) in terms of treatment response, overall survival, and progression-free survival in DLBCL patients. R-COMP may be a safe and effective option for elderly DLBCL patients or those with existing cardiac impairment.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Letter Hematology

The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age

Sylvain Mareschal et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Review Oncology

Lymphoma in older patients

Catherine Thieblemont et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Article Oncology

Revised response criteria for malignant lymphoma

Bruce D. Cheson et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)